Welcome
Most Viewed Brands (Last 24 hours)
My Company Logo
Brand Company Category City Digital Agency
Alfa VIP Industries Ltd Luggage, Bags Mumbai
e-Alfa Cargo Mahindra & Mahindra Ltd Commercial Vehicle Mumbai
e-Alfa Plus Mahindra & Mahindra Ltd Commercial Vehicle Mumbai
Select City
Search by Super Category
Apparel & Fashion Accessories
Apparel & Fashion Accessories
Automotive
Automotive
Beverages
Beverages
BFSI
BFSI
Consumer Durables
Consumer Durables
Consumer Electronics
Consumer Electronics
Foods
Foods
Household Products
Household Products
Offline & Online Retail
Offline & Online Retail
Personal Care
Personal Care

Got a question1? +91 9667582058*

Most Viewed Brands (Last 24 hours)

Got a question1? +91 9667582058*

Suggested Brands
Xiaomi
VIP
Carlton
Skybags
Media
Alfa Pro vs RayZR 125 Fi Hybrid: Price, Mileage & Range - ZigWheels.com

Published: August 21, 2026, 9:54 pm

Alfa Pro vs RayZR 125 Fi Hybrid: Price, Mileage & Range

Attending Classics on the Common car meet with my Alfa Romeo Spider - Team-BHP

Published: July 28, 2026, 7:00 am

Attending Classics on the Common car meet with my Alfa Romeo Spider

Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience - Business Wire

Published: August 19, 2026, 12:00 pm

Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature

Published: July 16, 2026, 7:00 am

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve paediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial - AstraZeneca

Published: June 28, 2026, 7:00 am

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve paediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial

Got a question? +91 9667582058*

My Company Logo
Suggested Brands
Xiaomi
VIP
Carlton
Skybags
Caprese
Alfa
Aristocrat
Ebags
Samsonite
Tumi